Haemonetics Corporation (HAE) Q1 2023 Earnings Results

Haemonetics Corporation Beats on EPS, Stock Up 8.89%

The earnings report indicates that Haemonetics Corporation is performing well, particularly in terms of earnings per share, which exceeded expectations. The stock reacted positively, rising 8.89%, likely driven by the EPS beat and management's optimistic outlook on operational performance. However, the lack of revenue data and guidance may leave some investors cautious.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.58	N/A	+8.82%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in the company's ability to navigate current market conditions. They emphasized a focus on long-term growth strategies.

Management highlighted strong operational performance despite market challenges.

They noted ongoing investments in innovation to drive future growth.

Haemonetics Corporation Beats on EPS, Stock Up 8.89%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corporation Beats on EPS, Stock Up 8.89%

Key numbers

Management commentary